K

Kazia Therapeutics Limited
D

KZIA

9.91000
USD
-0.03
(-0.30%)
مغلق
حجم التداول
1,503
الربح لكل سهم
-10
العائد الربحي
-
P/E
-0
حجم السوق
13,473,884
أصول ذات صلة
AZN
AZN
-1.055
(-1.43%)
72.640 USD
BMY
BMY
-0.525
(-1.07%)
48.455 USD
GSK
GSK
-0.250
(-0.65%)
37.965 USD
LLY
LLY
8.95
(1.11%)
812.95 USD
MRK
MRK
0.570
(0.68%)
84.730 USD
NVS
NVS
0.260
(0.22%)
117.680 USD
PFE
PFE
-0.555
(-2.19%)
24.810 USD
SNY
SNY
0.230
(0.46%)
50.370 USD
المزيد
الأخبار المقالات

العنوان: Kazia Therapeutics Limited

القطاع: Healthcare
الصناعة: Biotechnology
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.